Inverse agonist properties of antipsychotic agents at cloned, human (h) serotonin (5-HT)1B and h5-HT1D receptors

被引:37
作者
Audinot, V [1 ]
Newman-Tancredi, A [1 ]
Cussac, D [1 ]
Millan, MJ [1 ]
机构
[1] Inst Rech Servier, Dept Psychopharmacol, Dept Mol & Cellular Pharmacol, F-78290 Croissy Sur Seine, Paris, France
关键词
5-HT1B; 5-HT1D; schizophrenia; 5-5-schizophrenia; antipsychotic; clozapine; inverse agonist;
D O I
10.1016/S0893-133X(01)00237-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The actions of diverse antipsychotics at cloned h5-HT1B and h5-HT1D receptors were examined employing [H-3]-GR125,743 and [S-35]-GTP gammaS for determination of affinities and efficacies, respectively. Compared with hD(2) receptors, haloperidol, chlorpromazine and olanzapine showed markedly (> 100-fold) lower affinity for h5-HT1D and h5-HT1B receptors at which they expressed inverse agonist properties. Clozapine, risperidone and ocaperidone likewise behaved as inverse agonists at h5-HT1B and h5-HT1D receptors but their affinities were only similar to 10-fold lower than at hD2 receptors. Moreover, ziprasidone, S16924 and ORG5222 interacted at h5-HT1B and h5-HT1D receptors with affinities similar to hD(2) sites. While S16924 and ORG5222 were inverse agonists at h5-HT1B anti h5-HT1D sites, ziprasidone was an inverse agonist at h5-HT1D receptors yet a partial agonist tit h5-HT1B receptors. These actions of antipsychotics were abolished by the selective, neutral antagonist, S18127. In conclusion, with the exception cf ziprasidone, till antipsychotics were inverse agonists at h5-HT1B; and h5-HT1D receptors, although they differed markedly in their potency tit these sites as compared to hD(2) receptors. (C) 2001 American College of Neuropsychopharmacology. Published by Elsevier Science Inc.
引用
收藏
页码:410 / 422
页数:13
相关论文
共 101 条
[51]   A functional serotonin transporter (5-HTT) polymorphism is associated with psychosis in neuroleptic-free schizophrenics [J].
Malhotra, AK ;
Goldman, D ;
Mazzanti, C ;
Clifton, A ;
Breier, A ;
Pickar, D .
MOLECULAR PSYCHIATRY, 1998, 3 (04) :328-332
[52]   5-HT1B receptor knock-out mice exhibit increased exploratory activity and enhanced spatial memory performance in the Morris water maze [J].
Malleret, G ;
Hen, R ;
Guillou, JL ;
Segu, L ;
Buhot, MC .
JOURNAL OF NEUROSCIENCE, 1999, 19 (14) :6157-6168
[53]   Characterization of endogenous serotonin-mediated regulation of dopamine release in the rat prefrontal cortex [J].
Matsumoto, M ;
Togashi, H ;
Mori, K ;
Ueno, K ;
Miyamoto, A ;
Yoshioka, M .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 383 (01) :39-48
[54]   ACETYLCHOLINE-RELEASE FROM RAT HIPPOCAMPAL SLICES IS MODULATED BY 5-HYDROXYTRYPTAMINE [J].
MAURA, G ;
FEDELE, E ;
RAITERI, M .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 165 (2-3) :173-179
[55]   Mechanisms of agonism and inverse agonism at serotonin 5-HT1A receptors [J].
McLoughlin, DJ ;
Strange, PG .
JOURNAL OF NEUROCHEMISTRY, 2000, 74 (01) :347-357
[56]  
Meltzer Herbert Y., 1995, P1277
[57]   5-HT system and cognition [J].
Meneses, A .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1999, 23 (08) :1111-1125
[58]   SB-236057, a selective 5-HT1B receptor inverse agonist, blocks the 5-HT human terminal autoreceptor [J].
Middlemiss, DN ;
Göthert, M ;
Schlicker, E ;
Scott, CM ;
Selkirk, JV ;
Watson, J ;
Gaster, LM ;
Wyman, P ;
Riley, G ;
Price, GW .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 375 (1-3) :359-365
[59]  
Millan MJ, 2000, J PHARMACOL EXP THER, V292, P54
[60]   Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents [J].
Millan, MJ ;
Lejeune, F ;
Gobert, A .
JOURNAL OF PSYCHOPHARMACOLOGY, 2000, 14 (02) :114-138